Regulation of γ-globin gene expression involves signaling through the p38 MAPK/CREB1 pathway

Blood Cells, Molecules, and Diseases

Volumn 47, Issue 1, 2011, Pages 12-22

  Ramakrishnan, Valya ^a   Pace, Betty S ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

globin; CREB1; Globin gene regulation; P38 MAPK

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GAMMA GLOBIN; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROID CELL; ERYTHROLEUKEMIA CELL; GAMMA GLOBIN GENE; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CREB-BINDING PROTEIN; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ERYTHROID PRECURSOR CELLS; GAMMA-GLOBINS; GENE EXPRESSION REGULATION; GENE ORDER; HUMANS; K562 CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN BINDING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 79956317836     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2011.03.003     Document Type: Article

References (49)

1. Neiman A.M. Conservation and reiteration of a kinase cascade. Trends Genet. 1993, 9:390-394.
2. Nishida E., Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem. Sci. 1993, 18:128-131.
3. Martin-Blanco E. p38 MAPK signalling cascades: ancient roles and new functions. Bioessays 2000, 22:637-645.
4. Steinbrech D.S., Mehrara B.J., Saadeh P.B., Greenwald J.A., Spector J.A., Gittes G.K., et al. VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism. Am. J. Physiol. Cell Physiol. 2000, 278:C853-C860.
5. Tamura K., Sudo T., Senftleben U., Dadak A.M., Johnson R., Karin M. Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 2000, 102:221-231.
6. Nagata Y., Takahashi N., Davis R.J., Todokoro K. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 1998, 92:1859-1869.
7. Dean J.L., Brook M., Clark A.R., Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 1999, 274:264-269.
8. Krebs F.C., Goodenow M.M., Wigdahl B. Neuroglial ATF/CREB factors interact with the human immunodeficiency virus type 1 long terminal repeat. J. Neurovirol. 1997, 3(Suppl 1):S28-S32.
9. Montminy M.R., Bilezikjian L.M. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 1987, 328:175-178.
10. Sakamoto K.M., Fraser J.K., Lee H.J., Lehman E., Gasson J.C. Granulocyte-macrophage colony-stimulating factor and interleukin-3 signaling pathways converge on the CREB-binding site in the human egr-1 promoter. Mol. Cell. Biol. 1994, 14:5975-5985.
11. Johnson J., Hunter R., McElveen R., Qian X.H., Baliga B.S., Pace B.S. Fetal hemoglobin induction by the histone deacetylase inhibitor, scriptaid. Cell Mol. Biol. (Noisy-le-grand) 2005, 51:229-238.
12. Pace B.S., Qian X.H., Sangerman J., Ofori-Acquah S.F., Baliga B.S., Han J., et al. p38 MAP kinase activation mediates gamma-globin gene induction in erythroid progenitors. Exp. Hematol. 2003, 31:1089-1096.
13. Sangerman J., Lee M.S., Yao X., Oteng E., Hsiao C.H., Li W., et al. Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves gamma-globin activation by CREB1 and ATF-2. Blood 2006, 108:3590-3599.
14. Korzus E., Torchia J., Rose D.W., Xu L., Kurokawa R., McInerney E.M., et al. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 1998, 279:703-707.
15. Nakajima T., Uchida C., Anderson S.F., Parvin J.D., Montminy M. Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors. Genes Dev. 1997, 11:738-747.
16. Kasper L.H., Boussouar F., Ney P.A., Jackson C.W., Rehg J., van Deursen J.M., et al. A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis. Nature 2002, 419:738-743.
17. Dai P., Akimaru H., Tanaka Y., Hou D.X., Yasukawa T., Kanei-Ishii C., et al. CBP as a transcriptional coactivator of c-Myb. Genes Dev. 1996, 10:528-540.
18. Blobel G.A., Nakajima T., Eckner R., Montminy M., Orkin S.H. CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation. Proc. Natl Acad. Sci. U.S.A. 1998, 95:2061-2066.
19. Cheng X., Reginato M.J., Andrews N.C., Lazar M.A. The transcriptional integrator CREB-binding protein mediates positive cross talk between nuclear hormone receptors and the hematopoietic bZip protein p45/NF-E2. Mol. Cell. Biol. 1997, 17:1407-1416.
20. Zhang W., Bieker J.J. Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases. Proc. Natl Acad. Sci. U.S.A. 1998, 95:9855-9860.
21. Merika M., Orkin S.H. Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Kruppel family proteins Sp1 and EKLF. Mol. Cell. Biol. 1995, 15:2437-2447.
22. Han J., Lee J.D., Jiang Y., Li Z., Feng L., Ulevitch R.J. Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J. Biol. Chem. 1996, 271:2886-2891.
23. Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., Davis R.J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 1996, 16:1247-1255.
24. Kodeboyina S., Balamurugan P., Liu L., Pace B.S. cJun modulates Ggamma-globin gene expression via an upstream cAMP response element. Blood Cells, Mol. Dis. 2010, 44:7-15.
25. Fibach E., Rachmilewitz E.A. The two-step liquid culture: a novel procedure for studying maturation of human normal and pathological erythroid precursors. Stem Cells 1993, 11(Suppl 1):36-41.
26. Yao X., Kodeboyina S., Liu L., Dzandu J., Sangerman J., Ofori-Acquah S.F., et al. Role of STAT3 and GATA-1 interactions in gamma-globin gene expression. Exp. Hematol. 2009, 37:889-900.
27. Reuter C.W., Morgan M.A., Bergmann L. Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?. Blood 2000, 96:1655-1669.
28. Boosalis M.S., Bandyopadhyay R., Bresnick E.H., Pace B.S., Van Demark K., Zhang B., et al. Short-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation. Blood 2001, 97:3259-3267.
29. Ikuta T., Kan Y.W., Swerdlow P.S., Faller D.V., Perrine S.P. Alterations in protein-DNA interactions in the gamma-globin gene promoter in response to butyrate therapy. Blood 1998, 92:2924-2933.
30. Pace B.S., Chen Y.R., Thompson A., Goodman S.R. Butyrate-inducible elements in the human gamma-globin promoter. Exp. Hematol. 2000, 28:283-293.
31. Kwok R.P., Lundblad J.R., Chrivia J.C., Richards J.P., Bachinger H.P., Brennan R.G., et al. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 1994, 370:223-226.
32. Platt O.S., Brambilla D.J., Rosse W.F., Milner P.F., Castro O., Steinberg M.H., et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N. Engl. J. Med. 1994, 330:1639-1644.
33. Perrine S.P., Miller B.A., Faller D.V., Cohen R.A., Vichinsky E.P., Hurst D., et al. Sodiumbutyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia. Blood 1989, 74:454-459.
34. Cao H., Stamatoyannopoulos G., Jung M. Induction of human gamma globin gene expression by histone deacetylase inhibitors. Blood 2004, 103:701-709.
35. Atweh G.F., Sutton M., Nassif I., Boosalis V., Dover G.J., Wallenstein S., et al. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood 1999, 93:1790-1797.
36. Ley T.J., Desimone J., Noguchi C.T., Turner P.H., Schechter A.N., Heller P., et al. 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia. Blood 1983, 62:370-380.
37. Lavelle D.E. The molecular mechanism of fetal hemoglobin reactivation. Semin. Hematol. 2004, 41:3-10.
38. Haby C., Lisovoski F., Aunis D., Zwiller J. Stimulation of the cyclic GMP pathway by NO induces expression of the immediate early genes c-fos and junB in PC12 cells. J. Neurochem. 1994, 62:496-501.
39. Kuroyanagi Y., Kaneko Y., Muta K., Park B.S., Moi P., Ausenda S., et al. CAMP differentially regulates gamma-globin gene expression in erythroleukemic cells and primary erythroblasts through c-Myb expression. Biochem. Biophys. Res. Commun. 2006, 344:1038-1047.
40. King S.B. A role for nitric oxide in hydroxyurea-mediated fetal hemoglobin induction. J. Clin. Invest. 2003, 111:171-172.
41. Witt O., Sand K., Pekrun A. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood 2000, 95:2391-2396.
42. Park J.I., Choi H.S., Jeong J.S., Han J.Y., Kim I.H. Involvement of p38 kinase in hydroxyurea-induced differentiation of K562 cells. Cell Growth Differ. 2001, 12:481-486.
43. Cokic V.P., Andric S.A., Stojilkovic S.S., Noguchi C.T., Schechter A.N. Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells. Blood 2008, 111:1117-1123.
44. Hsiao C.H., Li W., Lou T.F., Baliga B.S., Pace B.S. Fetal hemoglobin induction by histone deacetylase inhibitors involves generation of reactive oxygen species. Exp. Hematol. 2006, 34:264-273.
45. Aerbajinai W., Zhu J., Gao Z., Chin K., Rodgers G.P. Thalidomide induces gamma-globin gene expression through increased reactive oxygen species-mediated p38 MAPK signaling and histone H4 acetylation in adult erythropoiesis. Blood 2007, 110:2864-2871.
46. Foulkes N.S., Laoide B.M., Schlotter F., Sassone-Corsi P. Transcriptional antagonist cAMP-responsive element modulator (CREM) down-regulates c-fos cAMP-induced expression. Proc. Natl Acad. Sci. U.S.A. 1991, 88:5448-5452.
47. Pissard S., Beuzard Y. A potential regulatory region for the expression of fetal hemoglobin in sickle cell disease. Blood 1994, 84:331-338.
48. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996, 84:321-330.
49. Hoeffler J.P., Meyer T.E., Yun Y., Jameson J.L., Habener J.F. Cyclic AMP-responsive DNA-binding protein: structure based on a cloned placental cDNA. Science 1988, 242:1430-1433.